AR 2021:
"For our stock price to match our book value’s compound rate of 18.2%, our stock price in Canadian dollars should be $1,335. And our intrinsic value exceeds book value, a principal reason being that our insurance companies generate huge amounts of float at no cost. This is the reason we continue to hold total return swaps with respect to 1.96 million subordinate voting shares of Fairfax with a total market value of $968 million at year-end."
AR 2020:
"Investment returns are very sensitive to end date values, so with a stock price of only $341 per share at the end of December 2020, our five and ten year and longer returns have been affected. We expect this to change as Fairfax begins to reflect intrinsic values again. Nothing that a $1,000 share price won’t solve!"
Also on the TRS, Prem said this in 2020:
"since the latter part of 2020 Fairfax has purchased total return swaps with respect to 1.4 million subordinate voting shares of Fairfax with a total market value at the time of those agreements of $484.9 million ($344.45 per share). We think this will be a great investment for Fairfax, perhaps our best yet!"
I don't see anything wrong with giving shareholders clues about intrinsic value, especially when the stock is trading meaningfully below IV.
Buffett gave clues when starting the share buyback. Ackman provided a share price in its latest report.
What's wrong is talking your stock up, with no regard to IV, like someone expecting 50% CAGR on her portfolio!